Norflex

Norflex is a brand name of orphenadrine, approved by the FDA in the following formulation(s):

NORFLEX (orphenadrine citrate - injectable; injection)

• 
  Manufacturer: MEDICIS
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 30MG/ML ^[RLD][AP]

Has a generic version of Norflex been approved?

Yes. The following products are equivalent to Norflex:

orphenadrine citrate injectable; injection

• 
  Manufacturer: AKORN
  
  Approval date: May 24, 2006
  
  Strength(s): 30MG/ML ^[AP]


• 
  Manufacturer: BEDFORD LABS
  
  Approval date: March 4, 2003
  
  Strength(s): 30MG/ML ^[AP]


• 
  Manufacturer: SAGENT PHARMS
  
  Approval date: August 30, 2011
  
  Strength(s): 30MG/ML ^[AP]


• 
  Manufacturer: WATSON LABS
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 30MG/ML ^[AP]


• 
  Manufacturer: WATSON LABS
  
  Approval date: March 15, 1982
  
  Strength(s): 30MG/ML ^[AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Norflex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Norflex.

See also...

• Norflex Consumer Information (Wolters Kluwer)
• Norflex Consumer Information (Cerner Multum)
• Norflex Advanced Consumer Information (Micromedex)
• Norflex Injection Advanced Consumer Information (Micromedex)
• Norflex AHFS DI Monographs (ASHP)
• Orphenadrine Consumer Information (Wolters Kluwer)
• Orphenadrine Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Orphenadrine Consumer Information (Cerner Multum)
• Orphenadrine Advanced Consumer Information (Micromedex)
• Orphenadrine Injection Advanced Consumer Information (Micromedex)
• Orphenadrine Citrate AHFS DI Monographs (ASHP)